These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9349434

  • 1. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine.
    Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD, Hoon DS.
    Gene Ther; 1997 Sep; 4(9):969-76. PubMed ID: 9349434
    [Abstract] [Full Text] [Related]

  • 2. [Construction of human MAGE-3 DNA vaccine and its immune effects observed in vivo].
    Liu XE, Sun XD, Wu JM.
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):165-9. PubMed ID: 15969102
    [Abstract] [Full Text] [Related]

  • 3. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
    Zhou WZ, Kaneda Y, Huang S, Morishita R, Hoon D.
    Gene Ther; 1999 Oct; 6(10):1768-73. PubMed ID: 10516727
    [Abstract] [Full Text] [Related]

  • 4. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.
    Hoon DS, Yuzuki D, Hayashida M, Morton DL.
    J Immunol; 1995 Jan 15; 154(2):730-7. PubMed ID: 7814879
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 15; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
    Sypniewska RK, Hoflack L, Tarango M, Gauntt S, Leal BZ, Reddick RL, Gravekamp C.
    Breast Cancer Res Treat; 2005 May 15; 91(1):19-28. PubMed ID: 15868428
    [Abstract] [Full Text] [Related]

  • 7. A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses.
    You Z, Hester J, Rollins L, Spagnoli GC, van der Bruggen P, Chen SY.
    Cancer Res; 2001 Jan 01; 61(1):197-205. PubMed ID: 11196161
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C, Sanda MG.
    Curr Opin Mol Ther; 1999 Aug 01; 1(4):471-9. PubMed ID: 11713762
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Anti-tumor immune responses of nanoemulsion-encapsulated MHS vaccine].
    Ge W, Sun YJ, Li Y, Zhang SH, Zhang XM, Huang Y, Hu PZ, Sui YF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May 01; 24(5):457-60. PubMed ID: 18466701
    [Abstract] [Full Text] [Related]

  • 17. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J.
    J Clin Virol; 2004 Dec 01; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC, Abrams JT, Zhang SY, Galili U.
    Cancer Res; 1999 Jul 15; 59(14):3417-23. PubMed ID: 10416604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.